Emmanouil Fokas

Mar 14, 2024 | nature.com | Yoshinori Kagawa |J. Joshua Smith |Emmanouil Fokas |Jun Watanabe |Florian R. Greten |Hideaki Bando | +3 more

AbstractDespite therapeutic advancements, disease-free survival and overall survival of patients with locally advanced rectal cancer have not improved in most trials as a result of distant metastases. For treatment decision-making, both long-term oncologic outcomes and impact on quality-of-life indices should be considered (for example, bowel function).